Amphastar Pharmaceuticals Poised for Growth: Strong Generic Pipeline and Strategic Marketing Drive Buy Rating

TipRanksApr 17 23:35

323 drugs, hurry up! America is facing the biggest “drug shortage” in history...

The US now seems to be facing an unprecedented “drug shortage”...

cls.cnApr 15 14:37

Amphastar Pharmaceuticals (NASDAQ:AMPH) Shareholders YoY Returns Are Lagging the Company's 66% Three-year Earnings Growth

Yahoo FinanceApr 12 22:26

Analysts Have Conflicting Sentiments on These Healthcare Companies: Amphastar Pharmaceuticals (AMPH), Ascendis Pharma (ASND) and AMN Healthcare Services (AMN)

TipRanksApr 12 21:41

Amphastar Pharmaceuticals Interested In Potential Acquisitions In Endocrinology-Focused Companies

At the Needham Healthcare Conference, Amphastar Pharmaceuticals Inc (NASDAQ:AMPH) highlighted why they remain excited about Baqsimi, the inhaled glucagon product for severe hypoglycemia. Amphastar Pha

BenzingaApr 11 03:23

Needham: Reiterates that Amphastar Pharma (AMPH.US) holds the rating.

Needham: Reiterates that Amphastar Pharma (AMPH.US) holds the rating.

Zhitong FinanceApr 10 19:30